Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
RIVERNORTH CAPITAL MANAGEMENT, LLC BYNO byNordic Acquisition Corp 13G 16.39% 2y
ARMISTICE CAPITAL, LLC BODI Beachbody Company, Inc. 13G 9.99% 2y
ALLIANCEBERNSTEIN L.P. VITL Vital Farms, Inc. 13G/A 0.5% 2y
EARNEST PARTNERS LLC CLB Core Laboratories Inc. 13G/A 8% 2y
GENERATION INVESTMENT MANAGEMENT LLP RELY Remitly Global, Inc. 13G/A 4.15% 2y
SPROTT INC. CTGO Contango Silver & Gold Inc. 13G/A 7.2% 2y
ARMISTICE CAPITAL, LLC OFIX Orthofix Medical Inc. 13G 9.79% 2y
COHEN & STEERS, INC. CPT Camden Property Trust 13G/A 7.24% 2y
RGM Capital, LLC AVNS Avanos Medical, Inc. 13G/A 6.83% 2y
Redmile Group, LLC HOOK HOOKIPA Pharma Inc. 13G/A 1.1% 2y
EdgePoint Investment Group Inc. BERY Berry Global Group, Inc. 13G/A 10.1% 2y
FRONTIER CAPITAL MANAGEMENT CO.,LLC MRC MRC GLOBAL INC. 13G 7.12% 2y
T. Rowe Price Investment Management, Inc. NYT New York Times Co 13G 5.6% 2y
Bares Capital Management, Inc. SSTI Soundthinking, Inc. 13G 5.81% 2y
ARMISTICE CAPITAL, LLC ALGS Aligos Therapeutics, Inc. 13G 9.99% 2y
FIR TREE CAPITAL MANAGEMENT LP BFAC Battery Future Acquisition Corp. 13G 6.77% 2y
COMPASS GROUP LLC VTRU Vitru Limited Common Shares 13G/A 14.1% 2y
Shaolin Capital Management LLC ARYD ARYA Sciences Acquisition Corp IV Class A Odinary Shares 13G 6.44% 2y
Point72 Asset Management, L.P. MORF Morphic Holding, Inc. Common Stock 13G/A 9.2% 2y
First Trust Capital Management L.P. MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares 13G 9.46% 2y
Deer IX & Co. L.P. ACVA ACV Auctions Inc. 13G/A 7.3% 2y
ARMISTICE CAPITAL, LLC KZIA Kazia Therapeutics Ltd 13G 9.99% 2y
Radcliffe Capital Management, L.P. CCTSF Cactus Acquisition Corp. 1 Ltd 13G/A 0% 2y
22NW Fund, LP PFX PhenixFIN Corp 13G/A 5.7% 2y
Avoro Capital Advisors LLC MRNS Marinus Pharmaceuticals, Inc 13G/A 5.8% 2y
Shaolin Capital Management LLC GMFI Aetherium Acquisition Corp. Class A Common Stock 13G/A 6.54% 2y
GREENLIGHT CAPITAL INC CNR Core Natural Resources, Inc. 13G/A 6.8% 2y
Avoro Capital Advisors LLC FOLD AMICUS THERAPEUTICS, INC. 13G/A 9.3% 2y
T. Rowe Price Investment Management, Inc. BLBD Blue Bird Corp 13G/A 0% 2y
FIR TREE CAPITAL MANAGEMENT LP OCAX OCA Acquisition Corp. Class A Common Stock 13G/A 0% 2y
ENDEAVOUR CAPITAL ADVISORS INC USCB Uscb Financial Holdings, Inc. 13G/A 6.7% 2y
PRICE T ROWE ASSOCIATES INC /MD/ PRTA Prothena Corp Public Ltd Co 13G/A 7.9% 2y
Abdiel Qualified Master Fund, LP GLBE Global-E Online Ltd. 13G/A 6.8% 2y
HG Vora Capital Management, LLC R Ryder System Inc 13G/A 5.5% 2y
Ionic Ventures, LLC SHFS SHF Holdings, Inc. 13G/A 0.3% 2y
Venrock Healthcare Capital Partners II, L.P. ACRS Aclaris Therapeutics, Inc. 13G/A 0% 2y
GLAZER CAPITAL, LLC MRT Marti Technologies, Inc. 13G/A 0% 2y
EW Healthcare Partners Fund 2 GP, L.P. TELA TELA Bio, Inc. 13G 16.79% 2y
MORGAN STANLEY AOMR Angel Oak Mortgage REIT, Inc. 13G/A 20.7% 2y
Thomas A. Satterfield, Jr. ARKR Ark Restaurants Corp 13G/A 14.86% 2y
Antara Capital LP XAGE Longevity Health Holdings, Inc. 13G/A 1.6% 2y
BECK MACK & OLIVER LLC TSQ Townsquare Media, Inc. 13G/A 5.8% 2y
Aristotle Capital Management, LLC LEN Lennar Corp 13G/A 4.32% 2y
ARMISTICE CAPITAL, LLC IDAI T Stamp Inc 13G 9.99% 2y
RA CAPITAL MANAGEMENT, L.P. COGT Cogent Biosciences, Inc. 13G/A 0% 2y
Kaufman Micha FVRR Fiverr International Ltd. 13G/A 7% 2y
Sanders Capital, LLC STX Seagate Technology Holdings plc 13G/A 7.41% 2y
Sculptor Capital LP NIR Near Intelligence, Inc. Common Stock 13G/A 0% 2y
Commodore Capital LP SABS SAB Biotherapeutics, Inc. 13G/A 3.5% 2y
Alain Bédard TFII TFI International Inc. 13G/A 6% 2y